257 related articles for article (PubMed ID: 30073465)
21. (E)-4-(3-(3,5-dimethoxyphenyl)allyl)-2-methoxyphenol inhibits growth of colon tumors in mice.
Zheng J; Park MH; Son DJ; Choi MG; Choi JS; Nam KT; Kim HD; Rodriguez K; Gann B; Ham YW; Han SB; Hong JT
Oncotarget; 2015 Dec; 6(39):41929-43. PubMed ID: 26474284
[TBL] [Abstract][Full Text] [Related]
22. P16 promotes the growth and mobility potential of breast cancer both in vitro and in vivo: the key role of the activation of IL-6/JAK2/STAT3 signaling.
Wang L; Zhan X; Shen X; Li M; Yang J; Yu W; Chen H; Jin B; Mao Z
Mol Cell Biochem; 2018 Sep; 446(1-2):137-148. PubMed ID: 29388151
[TBL] [Abstract][Full Text] [Related]
23. Scoparone exerts anti-tumor activity against DU145 prostate cancer cells via inhibition of STAT3 activity.
Kim JK; Kim JY; Kim HJ; Park KG; Harris RA; Cho WJ; Lee JT; Lee IK
PLoS One; 2013; 8(11):e80391. PubMed ID: 24260381
[TBL] [Abstract][Full Text] [Related]
24. Curcumol inhibits the expression of programmed cell death-ligand 1 through crosstalk between hypoxia-inducible factor-1α and STAT3 (T705) signaling pathways in hepatic cancer.
Zuo HX; Jin Y; Wang Z; Li MY; Zhang ZH; Wang JY; Xing Y; Ri MH; Jin CH; Xu GH; Piao LX; Ma J; Jin X
J Ethnopharmacol; 2020 Jul; 257():112835. PubMed ID: 32278762
[TBL] [Abstract][Full Text] [Related]
25. Sesquiterpene dimmer (DSF-27) inhibits the release of neuroinflammatory mediators from microglia by targeting spleen tyrosine kinase (Syk) and Janus kinase 2 (Jak2): Two major non-receptor tyrosine signaling proteins involved in inflammatory events.
Zeng KW; Wang S; Dong X; Jiang Y; Jin HW; Tu PF
Toxicol Appl Pharmacol; 2014 Mar; 275(3):244-56. PubMed ID: 24486434
[TBL] [Abstract][Full Text] [Related]
26. 8-benzyl-4-oxo-8-azabicyclo[3.2.1]oct-2-ene-6,7-dicarboxylic acid (SD-1008), a novel janus kinase 2 inhibitor, increases chemotherapy sensitivity in human ovarian cancer cells.
Duan Z; Bradner J; Greenberg E; Mazitschek R; Foster R; Mahoney J; Seiden MV
Mol Pharmacol; 2007 Nov; 72(5):1137-45. PubMed ID: 17675586
[TBL] [Abstract][Full Text] [Related]
27. 2-Methoxystypandrone inhibits signal transducer and activator of transcription 3 and nuclear factor-κB signaling by inhibiting Janus kinase 2 and IκB kinase.
Kuang S; Qi C; Liu J; Sun X; Zhang Q; Sima Z; Liu J; Li W; Yu Q
Cancer Sci; 2014 Apr; 105(4):473-80. PubMed ID: 24450414
[TBL] [Abstract][Full Text] [Related]
28. Carnosol induces apoptosis through generation of ROS and inactivation of STAT3 signaling in human colon cancer HCT116 cells.
Park KW; Kundu J; Chae IG; Kim DH; Yu MH; Kundu JK; Chun KS
Int J Oncol; 2014 Apr; 44(4):1309-15. PubMed ID: 24481553
[TBL] [Abstract][Full Text] [Related]
29. A Ferrocene Derivative Reduces Cisplatin Resistance in Breast Cancer Cells through Suppression of MDR-1 Expression and Modulation of JAK2/STAT3 Signaling Pathway.
Noori S; Nourbakhsh M; Farzaneh S; Zarghi A
Anticancer Agents Med Chem; 2020; 20(18):2285-2292. PubMed ID: 32767949
[TBL] [Abstract][Full Text] [Related]
30. 4-Methoxydalbergione suppresses growth and induces apoptosis in human osteosarcoma cells in vitro and in vivo xenograft model through down-regulation of the JAK2/STAT3 pathway.
Park KR; Yun HM; Quang TH; Oh H; Lee DS; Auh QS; Kim EC
Oncotarget; 2016 Feb; 7(6):6960-71. PubMed ID: 26755649
[TBL] [Abstract][Full Text] [Related]
31. 3-Deoxy-2β,16-dihydroxynagilactone E, a natural compound from Podocarpus nagi, preferentially inhibits JAK2/STAT3 signaling by allosterically interacting with the regulatory domain of JAK2 and induces apoptosis of cancer cells.
Shan H; Yao S; Ye Y; Yu Q
Acta Pharmacol Sin; 2019 Dec; 40(12):1578-1586. PubMed ID: 31201357
[TBL] [Abstract][Full Text] [Related]
32. Parthenolide Inhibits STAT3 Signaling by Covalently Targeting Janus Kinases.
Liu M; Xiao C; Sun M; Tan M; Hu L; Yu Q
Molecules; 2018 Jun; 23(6):. PubMed ID: 29921758
[TBL] [Abstract][Full Text] [Related]
33. Methylseleninic Acid Suppresses Breast Cancer Growth via the JAK2/STAT3 Pathway.
Qiu C; Zhang T; Zhu X; Qiu J; Jiang K; Zhao G; Wu H; Deng G
Reprod Sci; 2019 Jun; 26(6):829-838. PubMed ID: 30526368
[TBL] [Abstract][Full Text] [Related]
34. OPB-31121, a novel small molecular inhibitor, disrupts the JAK2/STAT3 pathway and exhibits an antitumor activity in gastric cancer cells.
Kim MJ; Nam HJ; Kim HP; Han SW; Im SA; Kim TY; Oh DY; Bang YJ
Cancer Lett; 2013 Jul; 335(1):145-52. PubMed ID: 23402820
[TBL] [Abstract][Full Text] [Related]
35. A pumpkin polysaccharide induces apoptosis by inhibiting the JAK2/STAT3 pathway in human hepatoma HepG2 cells.
Shen W; Chen C; Guan Y; Song X; Jin Y; Wang J; Hu Y; Xin T; Jiang Q; Zhong L
Int J Biol Macromol; 2017 Nov; 104(Pt A):681-686. PubMed ID: 28634059
[TBL] [Abstract][Full Text] [Related]
36. 10,11-dehydrocurvularin exerts antitumor effect against human breast cancer by suppressing STAT3 activation.
Zhao Q; Bi Y; Zhong J; Li X; Guo J; Liu YX; Pan LR; Tan Y; Deng ZS; Yu XJ
Acta Pharmacol Sin; 2021 May; 42(5):791-800. PubMed ID: 32868906
[TBL] [Abstract][Full Text] [Related]
37. S-adenosylmethionine induces apoptosis and cycle arrest of gallbladder carcinoma cells by suppression of JAK2/STAT3 pathways.
Liu Y; Bi T; Yuan F; Gao X; Jia G; Tian Z
Naunyn Schmiedebergs Arch Pharmacol; 2020 Dec; 393(12):2507-2515. PubMed ID: 32219484
[TBL] [Abstract][Full Text] [Related]
38. Induction of metastatic potential by TrkB via activation of IL6/JAK2/STAT3 and PI3K/AKT signaling in breast cancer.
Kim MS; Lee WS; Jeong J; Kim SJ; Jin W
Oncotarget; 2015 Nov; 6(37):40158-71. PubMed ID: 26515594
[TBL] [Abstract][Full Text] [Related]
39. Thymoquinone inhibits proliferation in gastric cancer via the STAT3 pathway in vivo and in vitro.
Zhu WQ; Wang J; Guo XF; Liu Z; Dong WG
World J Gastroenterol; 2016 Apr; 22(16):4149-59. PubMed ID: 27122665
[TBL] [Abstract][Full Text] [Related]
40. Regulation of Janus-activated kinase-2 (JAK2) by diindolylmethane in ovarian cancer in vitro and in vivo.
Kandala PK; Srivastava SK
Drug Discov Ther; 2012 Apr; 6(2):94-101. PubMed ID: 22622019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
